The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

The goals of therapy for BPH are to ameliorate LUTS, prevent related complications, and achieve measurable improvement in the patient's QOL. 3 In addition to drug and resource utilization costs, ...

Benign Prostatic Hyperplasia (BPH) is a common urological condition caused by the non-cancerous enlargement of the prostate gland. The prostate is a walnut sized gland that is part of the male ...

ED is a common comorbid condition in the aging man. 5,6 The Massachusetts Male Aging Study (MMAS) examined the prevalence of ED among men aged 40 to 70 years. 33 The prevalence of minimal, moderate, ...

An enlarged prostate is a condition that most commonly affects men over 50, but it can begin once you reach your 30s. This condition, often called benign prostatic hyperplasia or BPH, is non-cancerous ...

Once again, the topics of lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) received a great deal of attention at this year's meeting of the American Urological Association ...

New York, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with reassurance, ...

Intra-acinar and peri-acinar pressures in the prostate might be key factors in the evolution of its zonal morphology and the pathogenesis of BPH and cancer. Herein, I hypothesize that intra-acinar ...

Benign prostatic hyperplasia (BPH) has traditionally been considered a single disease entity, but genomic studies revealed different gene-expression profiles in individuals with symptomatic and ...

Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...